• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Innate Pharma S.A. - American Depositary Shares (NQ:IPHA)

2.250 +0.930 (+70.45%)
Streaming Delayed Price Updated: 1:12 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Innate Pharma S.A. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
May 13, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026
May 12, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update
May 06, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Participate in the D. Boral Capital Global Conference
April 23, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026
April 17, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026
April 13, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026
April 13, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event
April 08, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Participate in the Kempen Life Sciences Conference
April 03, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) and 2025 Form 20-f Annual Report
April 02, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Reports Full Year 2025 Financial Results and Business Update
March 26, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results
March 19, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
February 19, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
February 18, 2026
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
December 22, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Releases Its 2026 Financial Calendar
December 11, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
November 28, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Present at Jefferies Global Healthcare Conference
November 17, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
November 13, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
November 10, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
November 05, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
October 14, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Reports First Half 2025 Business Update and Financial Results
September 17, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event
September 15, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update
September 10, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025
September 02, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025
August 04, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference
July 29, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025
July 04, 2025
From Innate Pharma SA
Via Business Wire
News headline image
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
June 17, 2025
From Innate Pharma SA
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap